Access To Medicines

Every minute, somewhere in the world a woman or girl has an unsafe abortion. MSF is committed to providing safe abortion care to reduce avoidable suffering and deaths.

Unsafe abortion is one of the main causes of maternal death worldwide, and the only one that is almost entirely preventable.

Every day, our teams around the world witness first-hand the death and suffering caused by unwanted pregnancy and unsafe abortion.

That’s how we know that safe abortion care is essential healthcare.

MSF's Impact

In response to the need for better treatments, vaccines and diagnostic tests MSF set up its Access Campaign in 1999 to improve care for patients.

The aims of MSF Access Campaign are to:

  • Push for price cuts to medicines, vaccines and diagnostic tests by stimulating the production of more affordable generic products     
  • Act as a watchdog to ensure that the corporate interests don’t win out over public health needs     
  • Steer the direction of medical research toward urgently needed new drugs, vaccines and tests that don’t exist yet or are not tailored to the needs of people in developing countries     
  • Scope out, support and monitor new models to fund medical research that respond to medical rather than corporate needs and do not rely on charging sky high prices for the final product to pay for the research     

In 2003, MSF joined forces with six other organisations from around the world to establish the Drugs For Neglected Diseases Initiative (DNDi), with the aim of developing new drugs or new formulations of existing drugs for patients suffering from the most neglected communicable diseases.

DNDi seeks to address unmet needs by taking on projects that others are unable or unwilling to pursue.
 

MSF is well known for its humanitarian medical work, but it has also produced important research based on its field experience with vulnerable communities .

This website archives MSF's scientific articles and makes them available free, with full text and in an easily searchable format. MSF Field Research website.

MSF is also pushing for increased research into neglected diseases – such as tuberculosis, malaria, sleeping sickness and leishmaniasis – through increased funding, investing in research and development (R&D) capability in developing countries and supporting alternative models for R&D

Some treatments are no longer produced. MSF is calling on companies and governments to find solutions to bring unprofitable but medically necessary drugs back into production.

MSF is also supporting developing countries in codifying into law the "safeguards" that are allowed under international trade rules in order to protect access to medicines.

 
MSF, Doctors Without Borders, Access to diabetes treatment
Diabetes

Pharmaceutical corporations must make essential diabetes medicines affordable and accessible

Press Release 25 Sep 2024
 
MSF, Doctors Without Borders, Mpox, DRC
Democratic Republic of Congo (DRC)

In Eastern DRC, mpox is just another challenge amid a torrent of multiple problems

Patient and Staff Stories 5 Sep 2024
 
MSF, Doctors Without Borders,Abiy Adi Hospital, Ethiopia
Ethiopia

Recovery after Conflict at Abiy Adi Hospital, Ethiopia

Patient and Staff Stories 21 Aug 2024
 
Mpox Vaccines - Two health workers talk at the Budjala general hospital, supported by MSF. MSF also deployed a team in the Budjala health zone in South Ubangi to support health authorities in the response against Mpox.
Access To Medicines

Mpox Vaccines Must Increase in Accessibility

Latest News 20 Aug 2024
 
Life-saving care in Sudan: Adré, eastern Chad. A girl is getting vaccinated against measles by an MSF staff as part of a vaccination campaign carried-out by MSF in Adré transit camp.
Sudan

Five Ways to Bring Back Life-saving Care to Sudan

Patient and Staff Stories 7 Aug 2024
 
Palestinians in Hebron: Palestinians on their way back to their homes after visiting MSF mobile clinic in the Al-Majaz community in Masafer Yatta south of Hebron.
Palestine

Palestinians in Hebron, Gaza, Blocked from Medical Care

Latest News 5 Aug 2024